The ATG4B gene (Autophagy Related 4B) encodes a cysteine protease that plays a fundamental role in the autophagy pathway, the cell's primary degradation system for clearing damaged proteins, aggregates, and organelles. ATG4B is essential for processing the ATG8 family proteins (including LC3 and GABARAP subfamilies) that are critical for autophagosome biogenesis. This gene has garnered significant attention in the field of neurodegenerative disease research because autophagy is a key mechanism for clearing toxic protein aggregates that accumulate in Alzheimer's disease (amyloid-beta plaques, tau tangles), Parkinson's disease (α-synuclein Lewy bodies), and ALS (TDP-43 inclusions). ATG4B is located on chromosome 2q37.3 and encodes a 393-amino acid protein with protease activity. The gene is expressed ubiquitously with particularly high levels in the brain, liver, and kidney, reflecting its essential role in cellular homeostasis. Research has demonstrated that ATG4B activity and expression are often dysregulated in neurodegenerative conditions, making it a potential therapeutic target for enhancing autophagy-mediated clearance of pathological protein aggregates.
| Attribute | Value |
|---|---|
| Gene Symbol | ATG4B |
| Full Name | Autophagy Related 4B Cysteine Peptidase |
| Chromosome | 2q37.3 |
| NCBI Gene ID | 23192 |
| OMIM | 604353 |
| Ensembl ID | ENSG00000135679 |
| UniProt ID | Q9Y4P1 |
| Protein Size | 393 amino acids |
| Gene Type | Protein-coding |
ATG4B is a member of the ATG4 family of autophagic cysteine proteases, which in humans includes four paralogs: ATG4A, ATG4B, ATG4C, and ATG4D. Among these, ATG4B displays the broadest substrate specificity and highest catalytic activity toward ATG8 family proteins, making it the most important member for bulk autophagy. The protein contains a conserved catalytic domain with a cysteine protease active site (Cys74, Asp278, His275 in the catalytic triad) that recognizes the conserved LC3/GABARAP family proteins. The structural basis for ATG4B substrate recognition involves a deep substrate-binding groove that accommodates the N-terminal region of ATG8 proteins following their glycine residue exposure. ATG4B performs two essential enzymatic functions in the autophagy cycle:
ATG4B cleaves the C-terminal portion of newly synthesized ATG8 family proteins (LC3A, LC3B, LC3C, GABARAP, GABARAPL1, GABARAPL2) to expose a glycine residue at position 120 (LC3) or position 116 (GABARAP). This cleavage is prerequisite for the subsequent lipidation reaction that conjugates phosphatidylethanolamine (PE) to the exposed glycine, creating the membrane-associated form (LC3-II). Without ATG4B-mediated priming, ATG8 proteins cannot be lipidated and incorporated into the growing autophagosome.
Following autophagosome-lysosome fusion, ATG4B also performs a reverse reaction: it cleaves the PE moiety from LC3/GABARAP proteins that have completed their role in autophagy. This delipidation recycles the proteins back to their cytosolic form (LC3-I), allowing them to participate in additional rounds of autophagosome formation. This recycling function is essential for maintaining the pool of available ATG8 proteins and for proper autophagic flux.
ATG4B functions at a critical intersection in the autophagy pathway, bridging the synthesis of ATG8 family proteins with their deployment in autophagosome formation:
Autophagy (specifically macroautophagy) is a multi-step process involving:
ATG4B is essential for steps 2-3, where LC3/GABARAP proteins are required for membrane expansion and cargo recognition.
The ATG8 conjugation system involves:
The conjugation of PE to LC3 creates LC3-II, which serves two critical functions: it facilitates membrane expansion and closure, and it tethers cargo through interactions with autophagy receptors (p62/SQSTM1, OPTN, NDP52) that recognize ubiquitinated proteins and organelles. This cargo selection function makes autophagy essential for清除 aggregate-prone proteins in neurodegenerative diseases.
Beyond bulk autophagy, ATG4B supports several forms of selective autophagy:
In neurons, selective autophagy is particularly important for maintaining synaptic function and axonal homeostasis, as neurons are post-mitotic and cannot dilute damaged components through cell division.
ATG4B is expressed in all major brain cell types including neurons, astrocytes, microglia, and oligodendrocytes[@nixon2013]. In neurons, ATG4B localizes to the cytoplasm and is particularly enriched at synapses and in the axon initial segment, where autophagy is actively regulated.
Allen Human Brain Atlas — ATG4B Expression: Ubiquitous expression across all brain regions with particularly high levels in metabolically active neurons (cortex, hippocampus, cerebellum). Synaptic enrichment in pyramidal neurons. Astrocyte and microglia expression confirms broad cellular distribution. [@marino2003] [@wenz2018] The gene is upregulated under conditions of cellular stress, including nutrient deprivation, oxidative stress, and proteotoxic stress. Autophagy is especially important in neurons due to their unique architecture and post-mitotic nature. Axons and synapses are distant from the cell body, requiring local autophagic processes for maintenance. ATG4B-mediated autophagy is crucial for:
In Alzheimer's disease, autophagy is significantly impaired at multiple levels, and ATG4B function appears to be compromised. Key observations include:
The accumulation of toxic protein aggregates in AD may relate to ATG4B dysfunction, which limits the cell's ability to process LC3 and complete autophagy. Therapeutic strategies to enhance ATG4B activity could potentially restore autophagy flux and improve clearance of amyloid-beta and tau. Studies in mouse models have shown that overexpression of ATG4B or ATG5 enhances autophagy and reduces amyloid pathology.
ATG4B plays a particularly critical role in Parkinson's disease through its involvement in multiple PD-related pathways:
Studies have shown that ATG4B knockout mice develop progressive neurodegeneration with age, and ATG4B haploinsufficiency increases sensitivity to PD-like pathology. Conversely, ATG4B overexpression protects against dopaminergic neuron loss in MPTP and 6-OHDA models.
In ALS, autophagy dysfunction contributes to the accumulation of TDP-43 protein aggregates, which are the hallmark pathology in 95% of ALS cases. ATG4B is important for:
Autophagy is generally upregulated in ALS as a compensatory mechanism, but this response is often insufficient or impaired. Mutations in genes encoding autophagy proteins (including ATG5, ATG7, TBK1, OPTN) are associated with increased ALS risk, highlighting the importance of this pathway.
Although not a primary focus of this task, ATG4B is relevant to Huntington's disease as well. The mutant huntingtin protein is an autophagy substrate that accumulates due to impaired autophagic clearance. ATG4B activity is important for clearing polyglutamine-expanded huntingtin aggregates.
Several classes of compounds that enhance ATG4B activity are being investigated:
Since ATG4B acts within the broader autophagy pathway, broader strategies include:
Given the complexity of neurodegeneration, combination approaches may be most effective:
ATG4B expression and activity are regulated at multiple levels:
Several animal models have been used to study ATG4B in neurodegeneration:
Current research areas include:
The ATG4B gene encodes a critical enzyme in the autophagy pathway with significant implications for neurodegenerative disease. By processing ATG8 family proteins, ATG4B enables autophagosome formation and the clearance of toxic protein aggregates that accumulate in AD, PD, and ALS. While autophagy is generally impaired in these conditions, therapeutic strategies targeting ATG4B offer potential for restoring this essential cellular cleanup mechanism. Further research into ATG4B function and regulation will advance understanding of neurodegeneration and enable development of effective therapies.